CN104664401A - Soy isoflavone vitamin E soft capsule - Google Patents
Soy isoflavone vitamin E soft capsule Download PDFInfo
- Publication number
- CN104664401A CN104664401A CN201310621541.1A CN201310621541A CN104664401A CN 104664401 A CN104664401 A CN 104664401A CN 201310621541 A CN201310621541 A CN 201310621541A CN 104664401 A CN104664401 A CN 104664401A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- soft capsule
- isoflavones
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 239000007901 soft capsule Substances 0.000 title claims abstract description 21
- 229930003427 Vitamin E Natural products 0.000 title claims abstract description 11
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 title claims abstract description 11
- 235000019165 vitamin E Nutrition 0.000 title claims abstract description 11
- 229940046009 vitamin E Drugs 0.000 title claims abstract description 11
- 239000011709 vitamin E Substances 0.000 title claims abstract description 11
- 235000003687 soy isoflavones Nutrition 0.000 title abstract 5
- 239000000843 powder Substances 0.000 claims abstract description 28
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 21
- 108010010803 Gelatin Proteins 0.000 claims abstract description 11
- 235000019501 Lemon oil Nutrition 0.000 claims abstract description 11
- 229920000159 gelatin Polymers 0.000 claims abstract description 11
- 239000008273 gelatin Substances 0.000 claims abstract description 11
- 235000019322 gelatine Nutrition 0.000 claims abstract description 11
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 11
- 239000010501 lemon oil Substances 0.000 claims abstract description 11
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 6
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 29
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 29
- 235000008696 isoflavones Nutrition 0.000 claims description 29
- 229930003231 vitamin Natural products 0.000 claims description 11
- 239000011782 vitamin Substances 0.000 claims description 11
- 229940088594 vitamin Drugs 0.000 claims description 11
- 235000013343 vitamin Nutrition 0.000 claims description 11
- 235000019486 Sunflower oil Nutrition 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 10
- 239000002600 sunflower oil Substances 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- -1 25 parts Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000000084 colloidal system Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 230000006872 improvement Effects 0.000 abstract description 2
- 230000007102 metabolic function Effects 0.000 abstract description 2
- 230000008929 regeneration Effects 0.000 abstract description 2
- 238000011069 regeneration method Methods 0.000 abstract description 2
- 235000012041 food component Nutrition 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- 235000020238 sunflower seed Nutrition 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 description 6
- 229940011871 estrogen Drugs 0.000 description 6
- 239000000047 product Substances 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 230000003821 menstrual periods Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 206010065687 Bone loss Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000001072 progestational effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the technical field of health products, and particularly relates to a soy isoflavone vitamin E soft capsule. The soy isoflavone vitamin E soft capsule is characterized by comprising the following raw materials in parts by weight: 20-30 parts of soy isoflavone powder, 7-9 parts of pearl powder, 10-20 parts of vitamin E, 7-9 parts of sunflower seed oil, 3-5 parts of glycerinum, 3-5 parts of gelatin, 20-30 parts of water, 1.5-3.5 parts of lemon oil and 1.5-3.5 parts of titanium dioxide. The soy isoflavone vitamin E soft capsule can promote regeneration capacity of the skin, keep skin smooth, and has a good improvement effect on spots, so that skin maintains the young blood; moreover, the pearl powder ingredient is added, effective components of the pearl powder are utilized effectively, nutritional components required for human bodies are supplied and coordinated together, and the metabolic function of human bodies is improved so that the double effects of supplying nutritional ingredients for human bodies and keeping health are achieved.
Description
Technical field
The invention belongs to health product technology field, be specifically related to a kind of isoflavones dimension E soft capsule.
Background technology
Vitamin is the requisite material of human physiological functions and health, but whole demands of people can not be met by normal diet uptake, the vitamin needing supplement every day to lack, has become the daily life custom of many people at developed country's replenishing vitamins every day.
Vitamin E can promote reproduction.It can promote that sex hormone is secreted, and man's sperm motility and quantity is increased, woman's estrogen concentrations is increased, improves fecundity, prevention of miscarriage.There will be during TD and breed exception.Conventional vitamin E treatment threatened abortion and habitual abortion clinically.In addition, certain help is also had to male sterility.Other function aspects also have; protection T lymphocyte, protection red blood cell, anti-free oxygen base, Antiaggregating activity on platelet thus reduce the danger of myocardial infarction cerebral embolism, also have good curative effect to aspects such as burn, frostbite, capillary hemorrhage, climacteric metancholia, beauty treatments.
This series products of existing market is a lot, and ubiquity various problem, and a part of product effect is undesirable, although a part of product is fine, but dose is large and dependence is large.
Summary of the invention
The present invention, in order to overcome the deficiencies in the prior art, provides a kind of external-applied ointment for the treatment of gout.
Technical scheme of the present invention is: a kind of isoflavones dimension E soft capsule, this medicine by following raw materials according by weight ratio form: isoflavones powder 20-30 part, pearl powder 7-9 part, vitamin e1 0-20 part, sunflower oil 7-9 part, glycerine 3-5 part, gelatin 3-5 part, water 20-30 part, lemon oil 1.5-3.5 part, titanium dioxide 1.5-3.5 part.
A kind of isoflavones dimension E soft capsule, the optimum ratio of each component is: 25 parts, isoflavones powder, pearl powder 8 parts, vitamin e1 5 parts, sunflower oil 8 parts, glycerine 4 parts, 4 parts, gelatin, 25 parts, water, lemon oil 2.5 parts, titanium dioxide 2.5 parts.
Isoflavones powder is by the effective ingredients in plant extracted in crude soya bean, because it and estrogenic molecular structure are closely similar, can combine with the ERs in women's body, estrogen is played to the effect of bidirectional modulation, so be also called " phytoestrogen ".
The Main Function of isoflavones powder is as follows:
1, it is uncomfortable to improve menstrual period and climacteric, menstrual period and climacteric uncomfortable normal relevant with estrogen secretion imbalance, the long-term isoflavones that supplements can make estrogen level maintain normally, reaches the object improving discomfort in menstrual period.
2, prevention of osteoporosis and breast cancer, women, along with the reduction of estrogen secretion level, prevents the miopragia of the calcareous stripping of bone, causes bone-loss, if supplement isoflavones in time, can prevent bone-loss, prevention of osteoporosis.
3, improve psychosis after childbirth, after female fertility, progestational hormone reduces, and estrogen level not yet recovers, and therefore cause plant god disorderly, form phrenoblabia, isoflavones can supplement in time.
Containing the several amino acids of needed by human body and trace element in pearl, be easily absorbed by the body, there is nourishing blood and tranquilization, relieving palpitation arresting convulsion, heat-clearing enriching yin, improving eyesight, moisturizing please the effects such as face.
Vitamin E is hemorrhage antioxidant; it can stop unrighted acid (linoleic acid, arachidonic acid, other electron pair acceptor), vitamin, hormone, pigment, enzyme etc. from Oxidative demage; the peroxidating of lipid and albumen on cell membrane can not only be reduced; the normal function of Cell protection, and can also moisture be pinned.
A kind of preparation method of isoflavones dimension E soft capsule, step is as follows: by isoflavones powder, pearl powder, vitamin E, sunflower oil, glycerine, gelatin, lemon oil, be uniformly mixed, mixed feed liquid colloid mill is ground three mixings further, adding water, titanium dioxide filters after stirring, and then on soft capsule packing machine, pelleting obtains the present invention.
Beneficial effect: the present invention can promote skin power of regeneration, keep skin smooth, have good improvement result to spot, skin is retained youthful vitality.And because with the addition of pearl powder composition, effectively utilizing the active ingredient of pearl powder, the common nutritional labeling of supplementing, coordinating needed by human body, improves the metabolic function of body, reaches the double effects of supplementary body nutritional labeling and health care.
Detailed description of the invention
Be described principle of the present invention and feature below in conjunction with embodiment, example, only for explaining the present invention, is not intended to limit scope of the present invention.
Embodiment 1
A kind of isoflavones dimension E soft capsule, this medicine by following raw materials according by weight ratio form: 20 parts, isoflavones powder, pearl powder 7 parts, vitamin e1 0 part, sunflower oil 7 parts, glycerine 3 parts, 3 parts, gelatin, 20 parts, water, lemon oil 1.5 parts, titanium dioxide 1.5 parts.
A kind of preparation method of isoflavones dimension E soft capsule, step is as follows: by isoflavones powder, pearl powder, vitamin E, sunflower oil, glycerine, gelatin, lemon oil, be uniformly mixed, mixed feed liquid colloid mill is ground three mixings further, adding water, titanium dioxide filters after stirring, and then on soft capsule packing machine, pelleting obtains the present invention.
Embodiment 2
A kind of isoflavones dimension E soft capsule, this medicine by following raw materials according by weight ratio form: 25 parts, isoflavones powder, pearl powder 8 parts, vitamin e1 5 parts, sunflower oil 8 parts, glycerine 4 parts, 4 parts, gelatin, 25 parts, water, lemon oil 2.5 parts, titanium dioxide 2.5 parts.
A kind of preparation method of isoflavones dimension E soft capsule is with embodiment 1.
Embodiment 3
A kind of isoflavones dimension E soft capsule, this medicine by following raw materials according by weight ratio form: 30 parts, isoflavones powder, pearl powder 9 parts, vitamin E2 0 part, sunflower oil 9 parts, glycerine 5 parts, 5 parts, gelatin, 30 parts, water, lemon oil 3.5 parts, titanium dioxide 3.5 parts.
A kind of preparation method of isoflavones dimension E soft capsule is with embodiment 1.
Claims (3)
1. an isoflavones dimension E soft capsule, is characterized in that: this medicine by following raw materials according by weight ratio form: isoflavones powder 20-30 part, pearl powder 7-9 part, vitamin e1 0-20 part, sunflower oil 7-9 part, glycerine 3-5 part, gelatin 3-5 part, water 20-30 part, lemon oil 1.5-3.5 part, titanium dioxide 1.5-3.5 part.
2. a kind of isoflavones dimension E soft capsule according to claim 1, is characterized in that: the optimum ratio of each component is: 25 parts, isoflavones powder, pearl powder 8 parts, vitamin e1 5 parts, sunflower oil 8 parts, glycerine 4 parts, 4 parts, gelatin, 25 parts, water, lemon oil 2.5 parts, titanium dioxide 2.5 parts.
3. the preparation method of a kind of isoflavones dimension E soft capsule according to claim 1,2, it is characterized in that: step is as follows: by isoflavones powder, pearl powder, vitamin E, sunflower oil, glycerine, gelatin, lemon oil, be uniformly mixed, mixed feed liquid colloid mill is ground three mixings further, adding water, titanium dioxide filters after stirring, and then on soft capsule packing machine, pelleting obtains the present invention.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310621541.1A CN104664401A (en) | 2013-11-30 | 2013-11-30 | Soy isoflavone vitamin E soft capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310621541.1A CN104664401A (en) | 2013-11-30 | 2013-11-30 | Soy isoflavone vitamin E soft capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104664401A true CN104664401A (en) | 2015-06-03 |
Family
ID=53300406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310621541.1A Pending CN104664401A (en) | 2013-11-30 | 2013-11-30 | Soy isoflavone vitamin E soft capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104664401A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106509890A (en) * | 2016-10-31 | 2017-03-22 | 烟台新时代健康产业有限公司 | Composition for relieving female climacteric syndrome and preparation method thereof |
-
2013
- 2013-11-30 CN CN201310621541.1A patent/CN104664401A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106509890A (en) * | 2016-10-31 | 2017-03-22 | 烟台新时代健康产业有限公司 | Composition for relieving female climacteric syndrome and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zielińska et al. | Abundance of active ingredients in sea-buckthorn oil | |
| US7390507B2 (en) | Compositions and methods for the treatment of radiation burns and other traumatic skin conditions | |
| CN102919383A (en) | Blend oil containing peony seed oil and preparation method of blend oil | |
| KR20040068547A (en) | Breast pad assembly containing a skin benefit ingredient | |
| US10071030B2 (en) | Carrier comprising non-neutralised tocopheryl phosphate | |
| SI9620105A (en) | Two-stage preparation | |
| CN107136511A (en) | A kind of peony seed oil composition for promoting cranial nerve development, Peony-seed-oil soft capsule and preparation method thereof | |
| CN110558388A (en) | Formula of yak milk powder for old people and preparation method thereof | |
| JP2021172660A (en) | Chinese herbal medicine composition that treats insomnia and regulates renal function and its manufacturing method | |
| WO2019200364A1 (en) | Topical composition comprised of cod liver oil for treating wounds and skin disorders | |
| CN106343463A (en) | Royal jelly and beeswax lozenge and preparation method thereof | |
| CA2884745A1 (en) | Composition comprising plant phenols for preventing or reducing tewl and associated disorders and diseases | |
| WO2007051297A1 (en) | Oral skin supplement | |
| CN109010241A (en) | A kind of medicinal shin moisturizer and preparation method thereof for repairing skin keratin | |
| CN104664401A (en) | Soy isoflavone vitamin E soft capsule | |
| CN101999992A (en) | Fish scale collagen cosmetic | |
| CN111110833A (en) | A skin caring composition for oral administration and topical application, and its preparation method | |
| CN104474136A (en) | Plant essential oil for bra | |
| KR101010575B1 (en) | The composition for the atopic dermatitis improving with vinegar | |
| US11147761B2 (en) | Topical supplement composition and method of use | |
| CN105168067B (en) | A kind of vigor nti-freckle Essence and preparation method thereof | |
| WO2014001729A2 (en) | Compositions for topical application including a natural plant extract | |
| WO2014134834A1 (en) | Composition and food comprising same and preparation method of food | |
| CN102919853A (en) | Rana japonica oil soft capsule | |
| CN102885296B (en) | Formula of dietary supplement for female health care |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150603 |